News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
715,955 Results
Type
Article (43432)
Company Profile (356)
Press Release (672167)
Section
Business (211641)
Career Advice (2083)
Deals (36367)
Drug Delivery (94)
Drug Development (82125)
Employer Resources (172)
FDA (16652)
Job Trends (15270)
News (355677)
Policy (33330)
Tag
Academia (2683)
Alliances (52187)
Alzheimer's disease (1272)
Approvals (16585)
Artificial intelligence (164)
Bankruptcy (357)
Best Places to Work (11863)
Biotechnology (253)
Breast cancer (189)
Cancer (1345)
Cardiovascular disease (107)
Career advice (1742)
Cell therapy (283)
Clinical research (65397)
Collaboration (463)
Compensation (248)
COVID-19 (2625)
C-suite (112)
Data (1379)
Diabetes (164)
Diagnostics (6433)
Earnings (86506)
Employer resources (151)
Events (114648)
Executive appointments (375)
FDA (17295)
Funding (426)
Gene therapy (202)
GLP-1 (608)
Government (4433)
Healthcare (19403)
Infectious disease (2716)
Inflammatory bowel disease (113)
Interviews (320)
IPO (16690)
Job creations (3814)
Job search strategy (1489)
Layoffs (429)
Legal (8078)
Lung cancer (189)
Manufacturing (198)
Medical device (13934)
Medtech (13939)
Mergers & acquisitions (19813)
Metabolic disorders (439)
Neuroscience (1588)
NextGen Class of 2024 (6834)
Non-profit (4604)
Northern California (1659)
Obesity (252)
Opinion (192)
Patents (120)
People (58619)
Phase I (20492)
Phase II (28782)
Phase III (21373)
Pipeline (506)
Postmarket research (2580)
Preclinical (8801)
Radiopharmaceuticals (254)
Rare diseases (258)
Real estate (6216)
Regulatory (22203)
Research institute (2449)
Resumes & cover letters (361)
Southern California (1446)
Startups (3827)
United States (15132)
Vaccines (590)
Weight loss (180)
Date
Today (21)
Last 7 days (692)
Last 30 days (2655)
Last 365 days (36272)
2024 (35417)
2023 (41138)
2022 (52408)
2021 (57007)
2020 (55638)
2019 (48431)
2018 (36457)
2017 (33556)
2016 (33158)
2015 (39379)
2014 (32948)
2013 (27987)
2012 (30247)
2011 (30850)
2010 (28813)
Location
Africa (754)
Arizona (203)
Asia (39891)
Australia (6633)
California (3758)
Canada (1417)
China (297)
Colorado (173)
Connecticut (176)
Europe (87257)
Florida (517)
Georgia (138)
Illinois (392)
Indiana (224)
Kansas (99)
Maryland (627)
Massachusetts (2970)
Michigan (185)
Minnesota (294)
New Jersey (1084)
New York (1059)
North Carolina (774)
Northern California (1659)
Ohio (146)
Pennsylvania (912)
South America (1149)
Southern California (1446)
Texas (541)
Utah (110)
Washington State (403)
715,955 Results for "haematologic technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
HUTCHMED Highlights Publication of Phase III ESLIM-01 Results in The Lancet Haematology
HUTCHMED Limited announces that results from ESLIM-01, HUTCHMED’s Phase III trial of sovleplenib, in adult patients with primary immune thrombocytopenia in China, were published in The Lancet Haematology.
June 16, 2024
·
9 min read
Press Releases
ADC Therapeutics Announces The Lancet Haematology Publication of Data from Investigator-Initiated Trial Evaluating ZYNLONTA® in Combination with Rituximab to Treat Relapsed/Refractory Follicular Lymphoma
December 9, 2024
·
9 min read
Press Releases
Roche to present new and encouraging long-term follow-up data across broad haematology portfolio at ASH 2024
November 6, 2024
·
14 min read
Pharm Country
SELLAS Life Sciences to Present SLS009 Phase 1 Data from Acute Myeloid Leukemia Patients at the 2024 European School of Haematology (ESH) Conference: Updated Date and Time
SELLAS Life Sciences Group, Inc. today announced that the date and time for the presentation of data from the acute myeloid leukemia cohort of patients in the Phase 1 dose-escalation study of SLS009 (formerly GFH009) will be presented in an oral presentation at the 2024 European School of Haematology Acute Leukaemias (ESH) Conference.
February 29, 2024
·
3 min read
Press Releases
Update on Clinical Milestone - CytoMed Therapeutics Announces First Patient Dosed in its First-in-Human Phase I Clinical Trial of Allogeneic CAR-Gamma Delta T Cell Therapy in Patients with Advanced Solid Tumours or Haematological Malignancies
November 20, 2024
·
4 min read
Pharm Country
SELLAS Life Sciences to Present SLS009 Phase 1 Data from Acute Myeloid Leukemia Patients at the 2024 European School of Haematology (ESH) Conference
SELLAS Life Sciences Group, Inc. today announced that data from the acute myeloid leukemia cohort of patients in the Phase 1 dose-escalation study of SLS009 (formerly GFH009) will be presented in an oral presentation at the 2024 European School of Haematology Acute Leukaemias (ESH) Conference: 4th How to Diagnose and Treat Acute Leukaemias, taking place March 1-3, 2024, in Stockholm, Sweden.
January 25, 2024
·
3 min read
Pharm Country
Helius Medical Technologies, Inc. to Present at the Spring MicroCap Rodeo Conference 2024
Helius Medical Technologies, Inc. announced that it will participate in the Spring MicroCap Rodeo Conference to be held on Thursday, June 6th in NYC.
May 31, 2024
·
6 min read
Drug Development
Aptose Clinical and Preclinical Data to be Presented at European School of Haematology (ESH) 6th International Conference
Aptose Biosciences Inc. announced that two abstracts on tuspetinib, Aptose’s Phase 1/2 myeloid kinase inhibitor in development for acute myeloid leukemia, have been accepted for poster presentations at the European School of Haematology 6th International Conference: Acute Myeloid Leukemia “Molecular and Translational": Advances in Biology and Treatment, being held October 29-31, 2023, in Estoril, Portugal.
October 16, 2023
·
5 min read
News
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference
October 18, 2024
·
1 min read
Business
GT Medical Technologies, Inc. Appoints Two Industry Medical Device Veterans to Key Leadership Positions
GT Medical Technologies, Inc. today announced two significant additions to its leadership team: Tom Moore as Chief Commercial Officer and Sandeep Yadav as Chief Financial Officer.
June 20, 2024
·
2 min read
1 of 71,596
Next
